TNF and cancer: Our next study will focus on validation of these candidate genes filtered out in both nmMLCK and TNFα studies and generate a more accurate cancer prognosis platform with a refined gene set, which will lead to the development of cancer risk prediction/prognosis gene array in clinical trials.